Foster Corporation and AdvanSource Biomaterials Develop Marketing Partnership for Specialty TPU and TPU Alloy Products for Healthcare Market

Foster Corporation’s Distribution business, a leader in material solutions for the critical application healthcare market segment, has been appointed as the marketing partner for AdvanSource Biomaterials, a group company of Mitsubishi Chemical.

AdvanSource focuses on the manufacture and development of specialty thermoplastic polyurethane (TPU) products suited for specific application requirements. Foster’s role will entail application development, sales, and technical support, of AdvanSource products in the North American healthcare market from its U.S. locations in Connecticut and Nevada.

AdvanSource Biomaterials has developed, and offers for sale, an impressive line of thermoplastic polyurethane products for implantable and non-implantable healthcare applications. Their TPU technologies include polycarbonate aliphatic, polycarbonate aromatic, polyether aromatic, aliphatic ether, hydrophilic, as well as polycarbonate silicone elastomers and soft aromatic polyurethane alloys. Healthcare application segments include cardiology, orthopedics, drug delivery, endoscopy, wound care, urology, and neurology among others.

Foster Corporation knows TPU very well,” says Larry Acquarulo, President/Owner of Foster Corporation. “Our two companies have been talking about a sales/marketing relationship for a while. We are actually a customer of AdvanSource and have always been impressed with the quality of their product and their breadth of technology and elastomer solutions. Foster processes and sells materials for implantable applications which is also a market that AdvanSource participates in. This parallel interest makes this partnership a great match.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.